Pursuant to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, we wish to inform you that the Board of Directors at their Meeting held on 12th ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors of Southern Magnesium & Chemicals met on 12 November 2025 and approved the unaudited financial results for Q2 and half year ended 30 September 2025. For Q2 FY26, the company reported revenue from operations of ₹165.81 lakhs and a profit after tax of ₹20.73 lakhs (EPS ₹0.69). For H1 FY26, total income stood at ₹210.77 lakhs with PAT of ₹10.85 lakhs, which is a sharp drop from H1 FY25 total income of ₹1,009.39 lakhs and PAT of ₹291.75 lakhs. The Board also approved a change in designation of Mr. N Rajender Prasad from Joint Managing Director and CFO to Managing Director and CFO, effective 12 November 2025, for the remainder of his tenure till 09 August 2028. The statutory auditors issued an unqualified limited review report.
The year-on-year collapse in H1 revenue and profits is a significant red flag for shareholders, though Q2 standalone numbers appear more stable. The elevation of an existing promoter-director to MD & CFO role consolidates promoter control with no new external management appointment.